KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Payables (2016 - 2025)

Historic Payables for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $4.3 billion.

  • Eli Lilly's Payables rose 4765.98% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year increase of 4765.98%. This contributed to the annual value of $4.6 billion for FY2024, which is 2141.45% up from last year.
  • Latest data reveals that Eli Lilly reported Payables of $4.3 billion as of Q3 2025, which was up 4765.98% from $5.4 billion recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's Payables peaked at $5.4 billion during Q2 2025, and registered a low of $1.4 billion during Q1 2022.
  • For the 5-year period, Eli Lilly's Payables averaged around $2.9 billion, with its median value being $2.6 billion (2021).
  • Per our database at Business Quant, Eli Lilly's Payables soared by 8991.34% in 2021 and then tumbled by 1258.23% in 2022.
  • Quarter analysis of 5 years shows Eli Lilly's Payables stood at $2.6 billion in 2021, then increased by 15.32% to $2.9 billion in 2022, then rose by 27.82% to $3.8 billion in 2023, then grew by 21.41% to $4.6 billion in 2024, then fell by 6.84% to $4.3 billion in 2025.
  • Its Payables stands at $4.3 billion for Q3 2025, versus $5.4 billion for Q2 2025 and $3.4 billion for Q1 2025.